In recent years, a once-taboo topic has been making waves in unexpected places – the boardroom. Psychedelics, long associated with counterculture and recreational use, are gaining attention for their potential as cognitive enhancers and tools for personal development. Accordingly, for many professionals, microdosing psychedelics has become a critical part of their performance and mental wellness journey.
I am the perfect example of this trend: a former banker and venture capitalist, I spent 20 years in the financial services and technology industries. During my tenure, I have allocated several billion dollars to tech investments, led innovation for a large multinational corporation, and launched several companies. To stay competitive and improve my mental health, I strategically introduced micro-dosing psilocybin (magic mushrooms) into my routine. After doing so, I experienced tremendous results that have prompted a new growth sprout in my career.
In this article, I delve on the growing phenomenon of psychedelics in the boardroom.
